Drug Science, Policy and Law (DSPL)

Drug Science, Policy and Law is an international, peer-reviewed academic journal published by SAGE Publications in partnership with the Independent Scientific Committee on Drugs. First established in 2013, it provides a rigorous platform for multidisciplinary research on the complex interplay between the science of drugs and the legal and policy contexts that shape their regulation and societal impacts. The journal welcomes contributions from natural, behavioral, and social sciences, including addiction science, chemistry, psychiatry, psychology, criminology, forensic toxicology, and public policy. Its annual publication cycle brings together original research articles, systematic reviews, evidence-based analyses, and informed commentaries that explore both theoretical and practical dimensions of drug science and policy. Research published in this journal engages with contemporary issues such as harm reduction interventions, the neuropharmacological aspects of substance use, legal frameworks governing controlled substances, and the societal implications of policy decisions on drugs. Through rigorous peer review and a commitment to evidence-based discourse, Drug Science, Policy and Law serves academics, policymakers, health professionals, and legal scholars seeking to understand and influence the evolving landscape of drug research and regulation.

Drug Science, Policy and Law (DSPL) is :-

• International, Peer-Reviewed, Open Access, Refereed, Drug Discovery, Drug guides, Health Policy, psychopharmacology, forensic toxicology, psychiatry, psychology, criminology, legal studies and public policy, addressing high-impact issues on drug use effects, regulation, harm-reduction strategies, legal frameworks, and policy analysis affecting public health and society around drugs , Online , Yearly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2050-3245, Established: 2013,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE